Details of the Drug

General Information of Drug (ID: DMOX8LK)

Drug Name

NTx-265

Indication

Disease Entry	ICD 11	Status	REF
Stroke	8B20	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00663416) REGENESIS (CA): A Study of NTx 265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients. U.S. National Institutes of Health.